Neutral
Representative Gilbert Ray Cisneros, Jr. recently sold Medtronic (NYSE:MDT) shares valued between $1,001 and $15,000. This sale comes as Medtronic rep...
Neutral
Medtronic (MDT) is entering fiscal 2027 with guidance for continued organic growth and modest adjusted earnings expansion, trading at 14x forward earn...
Medtronic has received CE mark approval in Europe for its Stealth AXiS surgical navigation system for ear, nose, and throat (ENT) procedures. This exp...
Medtronic has announced FDA 510(k) clearance for its Nellcor™ pulse oximetry system featuring the new Nell-EQ™ intelligent processor. This technology ...
Medtronic has received FDA 510(k) clearance for its new Nellcor™ pulse oximetry system, which features the Nell-EQ™ intelligent processor. This techno...
Bullish
Medtronic has received FDA 510(k) clearance for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. This new processing technology...
Bullish
Medtronic (NYSE: MDT) reported strong Q4 2026 earnings, surpassing revenue estimates. The article details how investors can earn $500 monthly from Med...
Bullish
Medtronic plc announced mixed financial results for its fourth quarter of fiscal 2026, with revenue exceeding expectations at $9.81 billion, a 9.9% in...
Medtronic has submitted 510(k) filings to the FDA to expand the indications for its Hugo™ robotic-assisted surgery system into general and gynecologic...
Neutral
Medtronic PLC reported strong fiscal fourth-quarter earnings, with net income reaching $1.24 billion, or 96 cents per share. Adjusted earnings of $1.5...
Bullish
Medtronic has announced strategic investments in two privately held companies, Beluga Medical and CardioACC, both specializing in intracardiac echocar...
Mizuho has adjusted its price target for Medtronic (MDT) to $100, down from the previous target of $120. Despite this reduction, the firm has chosen t...
/Medtronic%20Plc%20logo-by%20360b%20via%20Shutterstock.jpg)
Neutral
Medtronic (MDT) stock has significantly underperformed the Nasdaq Composite (NASX) in both the short and long term, reflecting a decline of 24.2% over...
Neutral
National Pension Service increased its stake in Medtronic PLC (NYSE:MDT) by 1.0% in the fourth quarter, acquiring an additional 28,269 shares. The fun...
Neutral
Medtronic's Evolut TAVR device has shown superior clinical outcomes compared to Edwards' Sapien in a three-year head-to-head study, particularly in pa...
Neutral
Northwestern Mutual Wealth Management Co. significantly reduced its stake in Medtronic PLC (MDT) by 89% in the fourth quarter, selling over 150,000 sh...
Neutral
Medtronic Plc (NYSE:MDT) shares are projected to experience a 4.1% price movement following its earnings release on June 3, according to options data....
A new study published in the Journal of American College of Cardiology (JACC) reveals that over 77% of heart failure patients monitored with Medtronic...
Bullish
Medtronic is set to acquire SPR Therapeutics for $650 million, marking its third major acquisition of 2026. This acquisition will strengthen Medtronic...
Neutral
Clearstead Advisors LLC boosted its stake in Medtronic PLC (NYSE:MDT – Free Report) by 17.9% in the fourth quarter, HoldingsChannel.com reports. The f...